Digital Breast Tomosynthesis has assumed a central role in modern breast imaging, an ascension spurred on by progressive technological improvements. Thanks to uninterrupted research and an ongoing commitment to women's healthcare worldwide, Fujifilm is today able to further advance the value of its digital mammography solutions, improving workflow while boosting image quality performance to ever higher standards.
This year's Global Mammography Symposium will outline a suite of innovative technologies to further revolutionize the workflow of women's health practices. Synthetic 2D powered by a totally new iterative-based reconstruction, tomo-guided biopsy, and contrast-enhanced digital mammography are but some of the advances that will be discussed by an international clinical panel. Join us to discover how real-world facilities have adapted these new technologies into their unique and diverse practices and the new advances that have been made available by Fujifilm in this extremely dynamic market.
After this session, participants will be able to:
Describe mammography diagnostic and screening approaches from around the world and the factors influencing the global adoption of new technology.
Recognize differences in the appearance of breast cancer using digital breast tomosynthesis, synthetic 2D, contrast-enhanced digital mammography, and traditional diagnostic mammography and explain factors influencing the clinical performance of each subspecialty.
Identify ways in which incremental technological and workflow advances can improve patient outcomes.
Please continue to visit this event page for new information.
We look forward to seeing you at this exciting event!